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Abstract
It is generally assumed that the detection of disease susceptibility genes via fine-mapping association
study is facilitated by consideration of marker haplotypes. In this study, we compared the
performance of genotype-based and haplotype-based association studies using the Collaborative
Study of Genetics of Alcoholism dataset, on several chromosomal regions showing evidence for
linkage with ALDX1. After correction for multiple testing, the most significant results were
observed with the genotype-based analyses on two regions of chromosomes 2 and 7. Interestingly,
the analyses results from this dataset showed that there was no advantage of the haplotype-based
analyses over genotype-based (single-locus) analyses. However, caution should be taken when
generalizing these results to other chromosomal regions or to other populations.
Background
In fine-mapping of complex diseases, it is generally
assumed that the detection of susceptibility genes is facil-
itated by consideration of marker haplotypes.
Haplotype-based association methods could be more
powerful because they capture available linkage disequi-
librium (LD) information, but some lack of efficiency
could result from the resolution of the gametic phase.
When we have many loci to consider, as in the case in fine-
mapping of small chromosomal regions, the number of
possible haplotypes and degrees of freedoms increase
exponentially. On the other hand, the power of genotype-
based association test may suffer because LD information
contained in flanking markers is ignored.
In this study, we compared the performance of the geno-
type-based and the haplotype-based association analysis
using the Collaborative Study of Genetics of Alcoholism
(COGA) dataset, as released through the Genetic Analysis
Workshop 14 (GAW14). A large collection of families
containing multiple alcohol-dependent (AD) individuals
was systematically ascertained by the COGA through
probands treated for AD and having at least two other
first-degree relatives with AD. It is estimated that 50 to
60% of the variance in AD can be attributed to genetic fac-
tors [1,2] and is likely that alcoholism is a complex genetic
disorder that results from the action of multiple genes and
environmental influences [3,4]. Further, some studies
have shown evidence of linkage of AD to some regions on
chromosome 1, 2, 4, 7, and 11 [3-5]. In our study, we first
carried out a whole-genome scan to identify chromo-
somal regions linked to AD and then used a fine-scale
mapping on the significant regions by genotype- and hap-
lotype-based association tests. The relative advantages of
each approach are discussed in light of our analyses of the
COGA data.
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Methods
Data
The COGA data provided by GAW14 includes 143 fami-
lies with 1,614 individuals representing multiple ethnici-
ties. The data include information on family
relationships, discrete and quantitative phenotypes, cov-
ariates and genome-wide microsatellite genotypes and
single-nucleotide polymorphism (SNP) genotypes from
Affymetrix and Illumina as well as genetic maps for both
microsatellite and SNPs. We used the disease classifica-
tion, ALDX1 (AD based on the DSM-III-R and Feighner
definition), as the phenotype for genome scan and fine
mapping. ALDX1 is coded in five classes: pure unaffected,
never drank, unaffected with some symptoms, affected,
and unknown. We use a broad definition of ALDX1 by
combining the first three codings as unaffected.
Heritability and genome-wide linkage analysis
First, heritability estimates conditional on the proband's
status were computed using the program SOLAR [6]. Then
we conducted a preliminary linkage genome scan to iden-
tify the chromosomal regions linked to ALDX1. We used
these regions for fine-mapping and compared genotype-
and haplotype-based association tests. A multipoint
genome scan with microsatellite markers was performed
at each marker, using the nonparametric linkage approach
implemented in the program MERLIN [7] with ALDX1.
Genetic map distances were converted from Kosambi to
Haldane centimorgans as needed by MERLIN. Nine large
families were trimmed manually, leaving a total of 1,551
family members for the genome scan. Allele frequencies
were estimated using founders. Scans were performed
using nonparametric linkage (NPL) Spair and Sall statistics
[8]. COGA families represent multiple ethnicities that
could be genetically heterogeneous. Thus, we performed
genome scan analyses on the whole sample and on
Whites only (115 out of 143 families had a Whites
proband).
Fine-scale association mapping
To narrow down the candidate region showing the strong-
est evidence for linkage, we performed a fine-scale map-
ping approach using family-based association tests
(FBAT) [9]. We used SNPs and the SNP map given by
Affymetrix for the fine mapping in the regions identified
by multipoint genome scan. We used all families since
FBATs are robust to population admixture. Alleles trans-
mitted to affected offspring are compared with the
expected distribution of alleles among offspring. The
method is implemented in the software FBAT [10]. The
general "FBAT" statistic is based on a linear combination
of offspring genotypes and traits:
in which Xij denotes some function of the genotype Gij of
the jth offspring in family i at the locus being tested. Tij is
some function of the trait, depending upon possibly
unknown parameters. Two different approaches were
used based on either unphased genotype information
(genotype-based) or haplotypes inferred from genotypes
(haplotype-based). In the first approach, the FBAT test sta-
tistic is based on the distribution of the offspring geno-
types conditional on any trait information and on the
parental genotypes. In the second, offspring genotype pat-
terns Gij are phase-known and the genotype coding X(Gij)
is defined as[11]:
where k sums over the set of possible phased genotypes
that are compatible with Gij. The sum of weights 
over k equals 1. The weights are estimated by the condi-
tional probability of observing the phased genotype con-
ditional on the observed unphased genotype. Details
about the expectation maximization (EM) algorithm are
given in Horvath et al. [11]. Because we tested association
in the presence of linkage and the sample consists of fam-
ily data, a robust variance estimator for S was used [12].
Large families were broken into all possible nuclear fami-
lies, and their contribution to the test statistic was evalu-
ated independently.
Haplotypes were constructed using a 3-locus sliding-win-
dow. Two types of tests were performed: a biallelic test
(with 1 df) in which each haplotype is tested individually
and a multiallelic test in which the degrees of freedoms
equal the number of haplotypes minus one. Single-
marker tests of association (genotype-based) were carried
out in the presence of linkage under an additive model. To
correct for multiple testing, the false discovery rate (FDR)
principle [13] was applied. Further, for each 3-SNPs win-
dow, we calculated the mean LD (i.e., mean of pair-wise
LD between adjacent SNPs). LD was measured using
Lewontin's D' as estimated by the program GOLD [14].
Results
Heritability estimates and genome-wide multipoint 
linkage analysis
In the data, 38.8% were affected, 46.2% unaffected, and
the rest was unknown. Heritability of 41% with a standard
error of 0.17 was estimated for ALDX1 by SOLAR. Chro-
mosome regions showing evidence of linkage with
ALDX1 are depicted in Figure 1. The four plots represent
NPL score versus map distance based on multipoint link-
age analysis using Sall and Spair scoring functions in both
the whole sample and Whites only. There was no differ-
ence between both samples, therefore we only report the
ST X G E X G ij ij ij ij =− ∑ [ ( ) ( ( ))], ( ) 1
XG XG w ij ijk k Gijk () ( ) , ( ) =∑ 2
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results based on all families. The most significant region is
on chromosome 2, which spans marker D2S285 (88.5
cM) to marker D2S1331 (116.5 cM). There are 3 peaks
within this wide region. They are labeled as region 21,
region 22, and region 23 (Figure 1a). The maximum NPL
(Sall) scores on these regions were 2.92 (p = 0.002), 2.99
(p = 0.0014), and 2.99 (0.0014) at markers D2S285 (94.2
cM), D2S2109 (101.4 cM), and D2S1790 (114.2 cM),
respectively. Suggestive linkage (2.0<NPL<2.8) was also
found at different locations on chromosomes 2 (region
1), 7 (region 1, region 2, region 31, region 32, region 33),
11 (region 1), and 12 (D12S2078 (156.8 cM) – D12S392
(177.3 cM)).
Fine-scale linkage and association mapping
The numbers of SNPs used in fine-mapping at different
regions given by Figure 1 were 18 (chromosome 2 –
region 1, 1 SNP every 223 kb), 23 (chromosome 2 –
region 21, 1 SNP every 227 kb), 45 (chromosome 2 –
region 22, 1 SNP every 277 kb), 27 (chromosome 2 –
region 23, 1 SNP every 701 kb), 54 (chromosome 7 –
region 1 (NPY2 region), 1 SNP every 517 kb), 50 (chro-
mosome 7 – region 2, 1 SNP every 205 kb), 60 (chromo-
some 7 – region 31, 1 SNP every 200 kb), 47
(chromosome 7 – region 32, 1 SNP every 344 kb), 69
(chromosome 7 – region 33, 1 SNP every 300 kb), and 80
(chromosome 11 – region 1, 1 SNP every 203 kb). Most
of the single markers, and haplotypes which were found
statistically significant at the alpha = 0.05 level became
insignificant after FDR adjustment. Region 1 on chromo-
some 2 and 7 gave us some significant results after adjust-
ment (Figure 2, 2a–b). Figure 2a shows that SNP
tsc0095549 (8.55 cM) on chromosome 2 at region 1
remained significant after correction for multiple testing.
But the haplotypes around this SNP were not significant
even before correction. The SNP tsc0593964 (42.62 cM)
Multipoint NPL score profiles for chromosomes 2, 7, 11, and 12 for all and pairs options using all families and only Whites Figure 1
Multipoint NPL score profiles for chromosomes 2, 7, 11, and 12 for all and pairs options using all families and only Whites. 
Regions used for fine-mapping are also shown.
0 20 60 100 140 180 220 260
-2
-1
0
1
2
3
4
Chromosome 2 Position (cM)
N
P
L
 
S
c
o
r
e
all/NPL_ALL
all/NPL_Pairs
whites/NPL_ALL
whites/NPL_Pairs
r
e
g
i
o
n
1
r
e
g
i
o
n
2
1
r
e
g
i
o
n
2
2
r
e
g
i
o
n
2
3
0 20 40 60 80 100 140 180
-2
-1
0
1
2
3
4
Chromosome 7 Position (cM)
N
P
L
 
S
c
o
r
e
r
e
g
i
o
n
1
r
e
g
i
o
n
2
r
e
g
i
o
n
3
1
r
e
g
i
o
n
3
2
r
e
g
i
o
n
3
3
0 20 40 60 80 100 120 140 160
-2
-1
0
1
2
3
4
Chromosome 11 Position (cM)
N
P
L
 
S
c
o
r
e
r
e
g
i
o
n
1
0 20 40 60 80 100 120 140 160 180
-2
-1
0
1
2
3
4
Chromosome 12 Position (cM)
N
P
L
 
S
c
o
r
e
a) b)
c) d)BMC Genetics 2005, 6:S65
Page 4 of 6
(page number not for citation purposes)
Fine-mapping results from family-based association tests with SNP genotype and SNP haplotypes for region 1 of chromosome  2, 7, and 11 Figure 2
Fine-mapping results from family-based association tests with SNP genotype and SNP haplotypes for region 1 of chromosome 
2, 7, and 11. p-Values are adjusted for multiple testing by FDR. Mean LD values for each 3-SNPs window are also shown.
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on chromosome 7 at region 1 remained significant after
correction, but haplotypes of the SNP became insignifi-
cant after correction.
We also tested the flanking markers of several candidate
genes: ACP1 (tsc0582424, tsc0043640) on chromosome
2, NPY2 (tsc1107783, tsc0058867) and GRM3
(tsc0149750, tsc0040044) on chromosome 7, and DRD2
(tsc0108927, tsc0108926, tsc0108925) on chromosome
11 for association. But we could not find any significant
results for either single markers or haplotypes.
Discussion
In this study, several chromosomal regions on chromo-
somes 2, 7, 11, and 12 showed evidence for linkage with
ALDX1. Some of our results supported previous findings.
We were able to confirm some regions previously found
for AD on chromosomes 2 and 7. Specially, the region 2
on chromosome 2 and regions 1 and 33 on chromosome
7 are consistent with previous reports [4,5]. We found a
maximum NPL score of 2.18 exactly at the NPY2 gene in
our region 1 on chromosome 7. We found suggestive evi-
dence of linkage with AD on chromosome 11 around
D11S1998 marker, 10.9 cM downstream of DRD2 gene.
Fine-scale association mapping was then conducted in
these regions using unphased genotype-based and haplo-
type-based approaches. The power of single marker (gen-
otype-based) association test may suffer because LD
information contained in flanking markers is ignored.
Haplotype-based methods could be more powerful
because they capture available LD information. Surpris-
ingly, our results did not show any advantage of the hap-
lotype-based approach. Indeed, the most significant
results in the regions investigated, after correction for
multiple testing, were observed with the genotype-based
analyses (chromosome 2 – SNP tsc0095549 (8.55 cM)
and chr 7 – SNP tsc0593964 (42.62 cM)). Some possible
loss of efficiency of the haplotype-based method could
partly be explained by the uncertainty in the haplotype
inference from genotype due to the unknown phase of the
markers. Because SNPs are not very polymorphic markers,
phase ambiguity is likely to affect our results. To overcome
the problem of phase uncertainty, some studies consid-
ered the inferred haplotypes as true haplotypes. This was
not done in our study because this strategy could lead to
an inflation of type I error and overconfidence in the esti-
mate of the disease locus location [15]. Another explana-
tion is that when there is strong LD between the
unobserved causal locus and single marker (genotype),
the haplotypes do not carry additional information over
genotypes. Indeed, in this situation, a set of marker locus
genotypes can easily predict the causal locus while using
less degrees of freedom than haplotype-based tests of
association [16]. In the chromosomal regions investi-
gated, there were areas with high LD (D' > 0.6). In general,
the markers significant with the genotype-based analyses
are located within areas with high LD (Figure 2), but this
observation is not always consistent. This could suggest
that haplotype-based methods might be more advanta-
geous in regions with lower LD. In addition to size of LD,
there are other factors that contribute to the relative
advantage of each approach. The low densities of SNPs in
the studied chromosomal regions also make the compar-
ison of these two approaches difficult, because in this sit-
uation both have low power to detect association. It
should also be noted that in our analyses, the haplotype-
based test of association always involves more degrees of
freedom than the genotype-based test, while the same
number of tests are conducted with each approach. This
could penalize the haplotype-based approach. Therefore,
we repeated our analyses by replacing the p-value for the
global (i.e., multiallelic) haplotype test by the minimum
of the p-values of the individual biallelic haplotype tests
with 1 df. Our results remained unchanged. Also, there
might be more efficient methods to perform haplotype-
based analyses such as the cladistic analysis [17]. Further
studies are needed to better understand the relative advan-
tage of this approach.
Because the regions we investigated included many loci,
our findings may be obscured by multiple testing correc-
tions. Therefore, we also investigated several candidate
genes (ACP1, NPY2, GRM3, and DRD2) [18-22]. We did
not detect any associations with ALDX1, so the compari-
son of genotype-based and haplotype-based approaches
was not possible with COGA data with candidate genes.
We also investigated several candidate loci found by gen-
otype-based association (Figure 2a–b) and compared
both approaches without correction for multiple testing.
In all cases, the genotype-based analysis led to more sig-
nificant results, whether we used a multiallelic or a bial-
lelic haplotype test of association.
Conclusion
In conclusion, for this particular population and for the
regions investigated, there was no advantage of the haplo-
type-based analyses over (single-locus) genotype-based
analyses. However, caution should be taken when gener-
alizing these results to other chromosomal regions or to
other populations. The relative advantage of each
approach might be greatly related to the other factors such
as the extent of LD, and SNP density in the fine-mapping
regions.
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